Edwin Miranda is the newly appointed Chief Executive Officer of Cytovance Biopharmaceuticals. He will be taking the position of the vice president of quality Cytovance Biopharmaceuticals. He studied at Angelo University in San Angelo and graduated with a B.S in Biology and Chemistry. He was also serving his country in the Army before he retired.
Edwin Miranda had a successful career where he worked with several firms before joining Cytovance Pharmaceuticals. Some of the firms he served include Keppra where he supervised the quality assurance team and successfully managed get an FDA approval. Edwin Miranda also initiated the starting of the New Drug Application for Keppra. He also served as the vice president of quality assurance at URL mutual pharmaceuticals where he was in charge of the quality systems and oversaw regulatory compliance functions. He is also credited with coming up with a successful remediation plan.
Edwin Miranda has more than three decades of vast experience in the pharmaceutical industry. Therefore, his presence at Cytovance Pharmaceuticals will be a valuable asset to the entire organization. Consequently, he will bring vast experience in maintaining strict adherence to the set quality standards.
Miranda Edwin is also a senior loan consultant at the New American Funding. This firm is a national bank that issues mortgages to its customers. It was launched in the year 2003, and it operates a customer service Centre of more than 40 employees. Its principal focus is the delivery of quality service to its customers. It offers a wide variety of purchase home loans such as Cash-out mortgage’s, Jumbo and many others.
Under the leadership of Edwin Miranda, the New American Funding has been able to maximize its operations by enabling faster processing of mortgage loans where all the processes are done in the same house. The firm has enormous respect and dignity to its customers, employees and its partners.